-
Something wrong with this record ?
The miR-29 family in hematological malignancies
B. Fiserova, L. Kubiczkova, L. Sedlarikova, R. Hajek, S. Sevcikova
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
NT12130
MZ0
CEP Register
NT14575
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Source
Source
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
25004911
DOI
10.5507/bp.2014.037
Knihovny.cz E-resources
- MeSH
- Apoptosis genetics MeSH
- Extracellular Matrix genetics MeSH
- Hematologic Neoplasms genetics MeSH
- Humans MeSH
- MicroRNAs genetics physiology MeSH
- Cell Transformation, Neoplastic genetics MeSH
- Cell Proliferation genetics MeSH
- Cellular Senescence genetics MeSH
- Genes, Tumor Suppressor physiology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
BACKGROUND: MicroRNAs are short non-coding regulators of gene expression. The human miR-29 family consists of three members: miR-29a, miR-29b and miR-29c. Members of this family were found to be aberrantly expressed in various types of tumors, including hematological malignancies. This family was described to have both oncogenic and tumor suppressor features influencing various pathological processes, such as tumor growth and apoptosis. This review summarizes current knowledge about the miR-29 family in selected hematological malignancies. CONCLUSION: Recent research of miR-29 family in hematological malignancies has proven its oncogenic as well as tumor suppressive potential. Nevertheless, the level of current evidence is not sufficient, and data remain inconclusive.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17006074
- 003
- CZ-PrNML
- 005
- 20200219094214.0
- 007
- ta
- 008
- 170210s2015 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2014.037 $2 doi
- 035 __
- $a (PubMed)25004911
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Fišerová, Barbora $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 14
- $a The miR-29 family in hematological malignancies / $c B. Fiserova, L. Kubiczkova, L. Sedlarikova, R. Hajek, S. Sevcikova
- 520 9_
- $a BACKGROUND: MicroRNAs are short non-coding regulators of gene expression. The human miR-29 family consists of three members: miR-29a, miR-29b and miR-29c. Members of this family were found to be aberrantly expressed in various types of tumors, including hematological malignancies. This family was described to have both oncogenic and tumor suppressor features influencing various pathological processes, such as tumor growth and apoptosis. This review summarizes current knowledge about the miR-29 family in selected hematological malignancies. CONCLUSION: Recent research of miR-29 family in hematological malignancies has proven its oncogenic as well as tumor suppressive potential. Nevertheless, the level of current evidence is not sufficient, and data remain inconclusive.
- 650 _2
- $a apoptóza $x genetika $7 D017209
- 650 _2
- $a stárnutí buněk $x genetika $7 D016922
- 650 _2
- $a proliferace buněk $x genetika $7 D049109
- 650 _2
- $a nádorová transformace buněk $x genetika $7 D002471
- 650 _2
- $a extracelulární matrix $x genetika $7 D005109
- 650 _2
- $a tumor supresorové geny $x fyziologie $7 D016147
- 650 _2
- $a hematologické nádory $x genetika $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $x fyziologie $7 D035683
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bešše, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 mub2014851432
- 700 1_
- $a Sedlaříková, Lenka $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 xx0214571
- 700 1_
- $a Hájek, Roman, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $d 1964- $7 nlk20000083645
- 700 1_
- $a Ševčíková, Sabina, $d 1972- $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno $7 mub2015859787
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 2 (2015), s. 184-191
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170210 $b ABA008
- 991 __
- $a 20200219094616 $b ABA008
- 999 __
- $a ok $b bmc $g 1192599 $s 966721
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 159 $c 2 $d 184-191 $e 20140704 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NT12130 $p MZ0
- GRA __
- $a NT14575 $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20170210